Literature DB >> 6189472

Eyes with end-stage neovascular glaucoma. Natural history following successful modified filtering operation.

R Parrish, J Herschler.   

Abstract

A modified filtering operation for neovascular glaucoma provided control of intraocular pressure after 12 to 23 months in ten of 13 eyes. After long-term follow-up, 23 to 54 months, seven of ten eyes still had controlled IOP. Two eyes were receiving no medication, two required miotics, and three required maximal medical therapy, including carbonic anhydrase inhibitors. One eye had undergone cyclocryotherapy four years after trabeculectomy. Four of seven eyes with diabetic neovascular glaucoma retained ambulatory vision. The eye with neovascular glaucoma from central retinal vein occlusion lost useful vision. The underlying disease process is an important determinant of surviving visual function.

Entities:  

Mesh:

Year:  1983        PMID: 6189472     DOI: 10.1001/archopht.1983.01040010745008

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Cyclocryotherapy: a review of cases over a 10-year period.

Authors:  M T Benson; M E Nelson
Journal:  Br J Ophthalmol       Date:  1990-02       Impact factor: 4.638

3.  The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis).

Authors:  Peter A Netland
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

4.  Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma.

Authors:  Christopher C Shen; Sarwat Salim; Haiming Du; Peter A Netland
Journal:  Clin Ophthalmol       Date:  2011-03-01

5.  Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma.

Authors:  Hatem M Marey; Amin F Ellakwa
Journal:  Clin Ophthalmol       Date:  2011-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.